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Introduction 
      Migraine is a primary headache disorder and is 
ranked 19th among all diseases world-wide that cause 
disability (International Headache Society, 2013).  
There are more than 37 million Americans who 
experience migraine.  Migraine is most commonly 
experienced by individuals between the ages of 15 and 
55 and 70% to 80% of migraineurs have a family 
history of migraine (National Headache Foundation, 
2014). Migraine is the most common headache 
disorder for which patients obtain medical care 
(Minen, Tanev, & Friedman, 2014, p. 1131).  Estimated 
migraine healthcare costs in the United States are 
$19.6 billion annually (Da Silva & Tepper, 2012, p. 
824).  Migraine is often misdiagnosed and 
undertreated by healthcare providers.  The 
pathophysiology of migraine is complex and not fully 
defined; however, progress in understanding migraine 
pathophysiology has advanced in the last 20 years.  An 
understanding of migraine pathophysiology is 
necessary to provide acute and preventative treatment 
to individuals suffering from migraine. 
 
Signs and Symptoms 
      According to the International Classification of Headache Disorders (ICHD), a headache is diagnosed as a migraine when 
at least five headache attacks of the following criteria have 
occurred. The headache attacks last 4 to 72 hours.  The 
headache includes two of the four following characteristics, 
unilateral location, pulsating quality, moderate or severe pain 
intensity and is aggravated by or causes avoidance of routine 
physical activity.  Lastly, the headache is accompanied by at 
least one of the following, nausea or vomiting, photophobia or 
phonophobia (International Headache Society, 2013, p. 645).  A 
migraine has two main subtypes, migraine without aura and 
migraine with aura.  Migraine without aura is a clinical 
syndrome distinguished by a headache with precise features 
and associated symptoms. Migraine with aura is mainly 
characterized by the temporary focal neurological symptoms 
that precede or accompany the headache and it affects 
approximately one-fifth of migraine sufferers (International 
Headache Society, 2013). 
     A migraine attack consists of four phases that include  
premonitory (prodrome), aura, headache and resolution 
(postdrome); however, not every migraine sufferer experiences 
all four phases.  The premonitory phase can occur hours or days 
before the headache and may be a warning that a migraine attack 
is forthcoming.  The aura phase is the neurological symptoms 
that usually occur prior to the onset of the migraine attack. The 
headache phase is often the most debilitating part of the 
migraine attack and the headache pain can range from mild to 
severe. The  resolution phase is the recovery period immediately 
following the headache which may last hours or days.   
     Common symptoms of the premonitory and resolution phase 
may include hypoactivity, hyperactivity, feelings of well being or 
euphoria, depression, sleep issues, fatigue, nausea, diarrhea, 
food cravings, increased thirst, increased urination, 
phonophobia, photophobia, concentration problems, aphasia, 
repetitive yawning, pallor or neck stiffness and pain (American 
Headache Society Committee for Headache Education website, 
2014).  The aura phase can consist of visual, sensory, 
speech/language, motor, brainstem and retinal disturbances .  
The symptoms may include flashing lights, wavy lines or spots, 
partial loss of sight, blurry vision, monocular blindness, 
allodynia, aphasia, auditory or olfactory hallucinations, 
decrease/loss of hearing, confusion, dizziness, hemiplegia, 
paresthesia, reduced sensation, hiccups, and neck pain 
(American Headache Society Committee for Headache Education 
website, 2014).  The symptoms of the headache phase include 
unilateral headache pain, increased pain with physical activity, 
nausea and vomiting, diarrhea or constipation, dizziness, vertigo, 
confusion, hot flashes and chills, nasal congestion and/or runny 
nose, phonophobia, photophobia, osmophobia, depression, 
severe anxiety, and pain in the neck, eye, sinus and jaw areas 
(American Headache Society Committee for Headache Education 
website, 2014).   
     The National Headache foundation reports that less than half 
of all migraine sufferers have been diagnosed with migraine by 
their healthcare provider.  Currently, there is no test to diagnosis 
migraine; therefore, establishing the history of the migraine-
related symptoms and other headache characteristics in addition 
to a family history of similar headaches is used to diagnose a 
migraine headache (National Headache Foundation, 2014). 
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 Underlying Pathophysiology 
       Over the last several decades the understanding of migraine pathophysiology has advanced significantly; 
however, the exact migraine mechanisms are still unknown.  
Migraine is a complex brain disorder that is generally 
hereditary.  The predominant neurovascular theory implies 
that the migraine sufferer’s brain stays in a continual state of 
neuronal hyperexcitability.  A condition that may be partly due 
to decreased intracellular magnesium and increased levels of 
lactic acid (Kabat & Sowka, 2011, p. 102).  When certain 
trigger factors associated with a migraine such as bright lights, 
loud noise, certain odors or foods, missing or delaying a meal, 
hormonal changes, stress and depression are encountered a 
neurochemical imbalance develops.  This imbalance may be 
perceived by patients as the premonitory phase of a migraine 
attack (Kabat & Sowka, 2011, p. 102).  A depolarizing wave of 
neuron depression is eventually produced from ongoing 
conditions within the cortex and moves slowly across the 
cerebral cortex activating sensory nerves within the face and 
head (Kabat & Sowka, 2011, p. 102).  Neuropeptides are 
released from the trigeminal nerve, initiating platelet 
aggregation and release of serotonin.  Serotonin causes 
vasoconstriction and may be a contributing factor to the 
migraine aura (Kabat & Sowka, 2011, p. 102).  Neuropetides 
including substance P and calcitonin gene-related peptide 
(CGRP) incite inflammation of the meningeal arteries which is 
thought to activate the headache and other symptoms 
associated with a migraine attack (Kabat & Sowka, 2011, p. 
102-103).   
Significance of Pathophysiology 
     An understanding of migraine pathophysiology 
provides clarification in the approach to treatment.  
Activation of the trigeminovascular system causes 
peripheral sensitization, the early stage of a migraine 
attack.  Treatment during this phase of the migraine may 
terminate the attack fully (Ward, 2012, p. 758).  If the 
attack progresses further to central sensitization the 
attack becomes much harder to treat (Ward, 2012, p. 
758).   Acute treatment of migraine with specific 
medication may not always resolve a migraine attack.  For 
those individuals who experience frequent attacks or the 
attacks do not consistently respond to specific migraine 
treatment or medications, then preventative medications 
should be utilized to reduce migraine frequency and 
improve the response to the acute migraine medication.  
 Implications for Nursing Care 
       It is vital for healthcare professionals to have a good 
understanding of the pathophysiology of migraine, in 
order to accurately diagnose this neurological disorder 
and provide effective treatment.  Healthcare providers 
will need to perform a general and neurological exam of 
the patient and obtain a detailed, dedicated headache 
history from the patient.  Clinicians need to provide 
patient education regarding the disease process including 
the four phases of migraine, the triggering factors of 
migraine and the importance of identifying and avoiding 
these triggers as well as the appropriate use of 
medications and the significance of the timing of their use.  
A useful headache diagnosis tool for healthcare providers 
to utilize is the International Classification of Headaches 
guide. 
Conclusion 
       Migraine pathophysiology is complex and not fully 
defined; however, scientific advances have allowed 
healthcare providers to find correlations between the 
clinical features of migraine and changes in the brain that 
have enhanced the diagnostic accuracy for migraine 
(Ward, 2012, p. 753).  The question of whether migraine is 
primarily a vascular or neural abnormality has been 
essentially decided.  Vascular changes represent an 
epiphenomenon and migraine is a disorder of brain 
excitability and sensory dysmodulation that causes head 
pain along with associated features (Ward, 2012, p. 753).  
Migraine is usually a hereditary brain abnormality.  
Understanding hereditary brain alterations allows for 
optimal migraine treatment and for progression of 
knowledge concerning the underlying central nervous 
system abnormalities that make up migraine (Ward, 2012, 
p. 753).   
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